Form 4: Roivant Sciences CEO Sells Shares
Insider Transaction (Form 4)
Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd., sold 200,000 shares of common stock on August 28, 2026.
Summary
- Option exercise/conversion: acquired 200,000 Common Shares at $3.85 ($770,000) on August 28, 2026; holds 1,799,154 after (Direct).
- Open-market sale: disposed of 166,182 Common Shares at $35.63 ($5,921,065) on August 28, 2026; holds 1,632,972 after (Direct).
- Open-market sale: disposed of 33,818 Common Shares at $36.44 ($1,232,328) on August 28, 2026; holds 1,599,154 after (Direct).
- Option exercise/conversion: disposed of 200,000 Stock Option (Right to Buy) on August 28, 2026; holds 3,844,834 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $7,153,393 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Eric Venker — Officer (President & Immunovant CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Option exercise/conversion | Common Shares | 200,000 | $4 | $770.0K | 1,799,154 |
| 2026-08-28 | Open-market sale | Common Shares | 166,182 | $36 | $5.9M | 1,632,972 |
| 2026-08-28 | Open-market sale | Common Shares | 33,818 | $36 | $1.2M | 1,599,154 |
| 2026-08-28 | Option exercise/conversion | Stock Option (Right to Buy) | 200,000 | — | — | 3,844,834 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Option exercise/conversion (200,000 shares) |
| 2026-08-28 | Open-market sale (166,182 shares) |
| 2026-08-28 | Open-market sale (33,818 shares) |
| 2026-08-28 | Option exercise/conversion (200,000 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Eric Venker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.